Low Demand Hits PE‑Backed Anjan Drug’s Revenue
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Bottomline: Low demand weighs on PE-backed Anjan Drug’s revenue

Bottomline: Low demand weighs on PE-backed Anjan Drug’s revenue

By Nitesh Kumar

  • 02 Jul 2025
Premium
Bottomline: Low demand weighs on PE-backed Anjan Drug’s revenue
Credit: Pexels

Anjan Drug, a PAG-backed active pharmaceutical ingredient (API) manufacturer, reported a decline in revenue for the .........

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.